Literature DB >> 32016834

Cleistanthin A inhibits the invasion of MDA-MB-231 human breast cancer cells: involvement of the β-catenin pathway.

Siyuan Liu1,2, Lu Wang1, Wangwang Ding1, Dan Wang1, Xueting Wang1, Qianqian Luo1, Yapeng Lu3, Li Zhu4.   

Abstract

BACKGROUND: Cleistanthin A (CleA), a natural diphyllin glycoside, has been shown to suppress the invasion of cancer cells, but the underlying mechanisms remain unclear. Here, the inhibitory effect of CleA on the invasion of MDA-MB-231 human breast cancer cells was investigated, and the mechanisms involved were clarified.
METHODS: Cell viability was studied by MTT assay. The migration and invasion of MDA-MB-231 cells were assessed by wound healing assay and transwell assay, respectively. The enzymatic activity of matrix metalloproteinases (MMPs) was detected by gelatin zymography. mRNA and protein levels were detected by qRT-PCR and Western blotting, respectively. Nuclear translocation of β-catenin was observed by immunofluorescence and detected by Western blotting.
RESULTS: CleA effectively inhibited the migration and invasion of MDA-MB-231 cells and suppressed the expression and activation of MMP-2/9. Moreover, the expression and nuclear translocation of β-catenin were reduced by CleA treatment, as well as transcription of the Cyclin D1 and c-myc genes. In addition, the inhibitory effect of CleA on the β-catenin pathway was attributed to the promotion of β-catenin degradation by inhibition of GSK3β phosphorylation. When the phosphorylation of GSK3β was induced by LiCl, the inhibitory effect of CleA on the β-catenin pathway and the invasion of MDA-MB-231 cells were almost reversed.
CONCLUSION: CleA suppressed the invasion of MDA-MB-231 cells, likely through the β-catenin pathway.

Entities:  

Keywords:  Cleistanthin A; Human breast cancer cells; Invasion; β-catenin

Mesh:

Substances:

Year:  2019        PMID: 32016834     DOI: 10.1007/s43440-019-00012-1

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  39 in total

Review 1.  Wnt/β-catenin signaling and disease.

Authors:  Hans Clevers; Roel Nusse
Journal:  Cell       Date:  2012-06-08       Impact factor: 41.582

2.  Synthesis and bioevaluation of heterocyclic derivatives of Cleistanthin-A.

Authors:  Yu Zhao; Rui Zhang; Yapeng Lu; Jinlong Ma; Li Zhu
Journal:  Bioorg Med Chem       Date:  2015-05-27       Impact factor: 3.641

3.  Cleistanthin A causes DNA strand breaks and induces apoptosis in cultured cells.

Authors:  C P Pradheepkumar; N Panneerselvam; G Shanmugam
Journal:  Mutat Res       Date:  2000-01-24       Impact factor: 2.433

4.  Cytotoxic and genotoxic effects of cleistanthin B in normal and tumour cells.

Authors:  C Prabhakaran; P Kumar; N Panneerselvam; S Rajesh; G Shanmugam
Journal:  Mutagenesis       Date:  1996-11       Impact factor: 3.000

5.  Anticancer potential of cleistanthin A isolated from the tropical plant Cleistanthus collinus.

Authors:  C P Pradheepkumar; G Shanmugam
Journal:  Oncol Res       Date:  1999       Impact factor: 5.574

6.  Cleistanthin A inhibits the invasion and metastasis of human melanoma cells by inhibiting the expression of matrix metallopeptidase-2 and -9.

Authors:  Sheng Pan; Hengji Cai; Lixiong Gu; Shuanglin Cao
Journal:  Oncol Lett       Date:  2017-09-08       Impact factor: 2.967

7.  Requirement of prorenin receptor and vacuolar H+-ATPase-mediated acidification for Wnt signaling.

Authors:  Cristina-Maria Cruciat; Bisei Ohkawara; Sergio P Acebron; Emil Karaulanov; Carmen Reinhard; Dierk Ingelfinger; Michael Boutros; Christof Niehrs
Journal:  Science       Date:  2010-01-22       Impact factor: 47.728

Review 8.  Metastasis: from dissemination to organ-specific colonization.

Authors:  Don X Nguyen; Paula D Bos; Joan Massagué
Journal:  Nat Rev Cancer       Date:  2009-04       Impact factor: 60.716

9.  Biodistribution properties of cleistanthin A and cleistanthin B using magnetic resonance imaging in a normal and tumoric animal model.

Authors:  Subramani Parasuraman; Ramasamy Raveendran; Mehdi Shafiee Ardestani; Ramesh Ananthakrishnan; Ali Jabbari-Arabzadeh; Mohammad Shafiee Alavidjeh; Mohammad Reza Aghasadeghi; Sundararajan Elangovan; Halanaik Dhanapathi
Journal:  Pharmacogn Mag       Date:  2012-04       Impact factor: 1.085

10.  Sub-chronic toxicological evaluation of cleistanthin A and cleistanthin B from the leaves of Cleistanthus collinus (Roxb.).

Authors:  Subramani Parasuraman; Ramasamy Raveendran; Nachiappa Ganesh Rajesh; Subbiah Nandhakumar
Journal:  Toxicol Rep       Date:  2014-08-19
View more
  2 in total

1.  Diphyllin Shows a Broad-Spectrum Antiviral Activity against Multiple Medically Important Enveloped RNA and DNA Viruses.

Authors:  Michal Štefánik; Dattatry Shivajirao Bhosale; Jan Haviernik; Petra Straková; Martina Fojtíková; Lucie Dufková; Ivana Huvarová; Jiří Salát; Jan Bartáček; Jan Svoboda; Miloš Sedlák; Daniel Růžek; Andrew D Miller; Luděk Eyer
Journal:  Viruses       Date:  2022-02-09       Impact factor: 5.048

2.  Knockdown of ATG4A inhibits breast cancer progression and promotes tamoxifen chemosensitivity by suppressing autophagy.

Authors:  Qingfang Li; Lingling Zan
Journal:  Mol Med Rep       Date:  2022-01-28       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.